Expanding on the biomechanical and design principles of X-CORE,® the X-CORE 2 Expandable VBR is designed to be the latest and most advanced all-approach expandable VBR on the market. The X-CORE 2 Expandable VBR provides expanded versatility that enables surgeons to utilize X-CORE technology – not only via the XLIF ® approach, but also through multiple approaches – and offers further customizability of the implant through increased sizing options. All of this is achievable through unique implant updates, and via streamlined, minimally disruptive instrumentation.
Benefits:
Biomechanical Strength
- XLIF Endcaps – Increased Resistance to Subsidence
- Increased Graft Aperture
- Enhanced Anti-Migration
Versatile
- All-Approach Solution
Customizable
- Three Core Diameters
- Maximized Height Span
- 75+ Endcap Options
Minimally Disruptive
- Zero Profile Inserter/Expander
- Seamlessly Integrated System
About Expandable Corpectomy Devices
Each year, there are more than 150,000 spinal fractures in North America*. There is an estimated 10,000 to 12,000 spinal cord injuries every year and approximately 39% of these injuries are cause by motor vehicle accidents4. These non-elective or trauma surgeries sometimes require additional spinal structural support which is when the Expandable Corpectomy Device are used.Another indication or use for these Devices is in the treatment of cancer patients. If the cancer metastasizes or spreads in the spine, the surgeon may opt to remove the affected vertebral bodies and replace them with an Expandable Corpectomy Device.*(http://emedicine.medscape.com/article/1264191-overview)
About NuVasive
NuVasive, Inc. (NASDAQ: NUVA) is transforming spine surgery and beyond with minimally invasive, procedurally-integrated solutions designed to deliver reproducible and clinically-proven surgical outcomes. The Company’s portfolio includes access instruments, implantable hardware, biologics, software systems for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative monitoring service offerings. With $962 million in revenues (2016), NuVasive has an approximate 2,300 person workforce in more than 40 countries serving surgeons, hospitals and patients. For more information, please visit www.nuvasive.com.